美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=SODIUM PHOSPHATES"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
SODIUM PHOSPHATES IN PLASTIC CONTAINER 018892 001 NDA SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SOLUTION;INTRAVENOUS 4.02GM/15ML;4.14GM/15ML (268MG/ML;276MG/ML) Yes Yes 1983/05/10 1983/05/10 HOSPIRA Prescription
SODIUM PHOSPHATES 209997 001 ANDA SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SOLUTION;INTRAVENOUS 1.34GM/5ML;1.38GM/5ML (268MG/ML;276MG/ML) No Yes 2022/03/30 2022/03/30 FRESENIUS KABI USA Prescription
SODIUM PHOSPHATES 209997 002 ANDA SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SOLUTION;INTRAVENOUS 4.02GM/15ML;4.14GM/15ML (268MG/ML;276MG/ML) No No 2022/03/30 2022/03/30 FRESENIUS KABI USA Prescription
SODIUM PHOSPHATES 209997 003 ANDA SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SOLUTION;INTRAVENOUS 13.4GM/50ML;13.8GM/50ML (268MG/ML;276MG/ML) No Yes 2022/03/30 2022/03/30 FRESENIUS KABI USA Prescription
SODIUM PHOSPHATES 218314 001 ANDA SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SOLUTION;INTRAVENOUS 1.34GM/5ML;1.38GM/5ML (268MG/ML;276MG/ML) No No 2024/06/21 2024/06/21 AM REGENT Prescription
SODIUM PHOSPHATES 218314 002 ANDA SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SOLUTION;INTRAVENOUS 4.02GM/15ML;4.14GM/15ML (268MG/ML;276MG/ML) No No 2024/06/21 2024/06/21 AM REGENT Prescription
SODIUM PHOSPHATES 218314 003 ANDA SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SOLUTION;INTRAVENOUS 13.4GM/50ML;13.8GM/50ML (268MG/ML;276MG/ML) No No 2024/06/21 2024/06/21 AM REGENT Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database